Atlas Trials

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV

Clinical trial NCT04910711 · UNKNOWN

Trial details

NCT number
NCT04910711
Sponsor
Botswana Harvard AIDS Institute Partnership
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Human Immunodeficiency VirusContraceptionART
Start date
2021-10-21
Primary completion
2023-08-31
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.